Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation TCT 2022

Lifetime Management, Durability and Clinical Relevance to Patients

Presenter: John Webb

September 17, 2022

Presentation TCT 2021

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Presenter: Alexandra Lansky

November 06, 2021

Presentation TCT 2021

Establishing Consensus: US Guidance Updates

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

Presentation TCT 2021

Latest Evidence in the SPYRAL-HTN Clinical Program

Presenter: NULL

November 05, 2021

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

Presentation TCT 2020

I Recommend Renal Denervation!

Presenter: Andrew Sharp

October 17, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

Presentation TCT 2020

TCT ID 7: Everolimus-Eluting Stent vs Bare-Metal Stent in ST-Segment Elevation Myocardial Infarction – 10-Year Follow-up of the Multicentre Randomized Controlled Examination Trial

Presenter: Salvatore Brugaletta

October 15, 2020

Presentation TCT 2020

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Michael Megaly

October 15, 2020

Presentation TCT 2020

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

Presenter: Robert Smith

October 15, 2020

Presentation TCT 2020

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

Presenter: Benjamin Peterson

October 15, 2020

Presentation TCT 2020

TCT ID 2: The PASCAL Transcatheter Valve Repair System for the Treatment of Tricuspid Regurgitation – Day Outcomes From the CLASP TR Early Feasibility Study

Presenter: Charles Davidson

October 15, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

Advertisement

Lifetime Management, Durability and Clinical Relevance to Patients

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Establishing Consensus: US Guidance Updates

Leading with Evidence: Latest Data on Renal Denervation

Latest Evidence in the SPYRAL-HTN Clinical Program

Failed MitraClip Is Uncommon, but Bleak When It Happens

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Treating Accessory Arteries May Be Important in Renal Denervation

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

I Recommend Renal Denervation!

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

TCT ID 7: Everolimus-Eluting Stent vs Bare-Metal Stent in ST-Segment Elevation Myocardial Infarction – 10-Year Follow-up of the Multicentre Randomized Controlled Examination Trial

TCT ID 6: Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement

TCT ID 5: Six-Month and One-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study

TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention – Insights From REDUCE-IT PCI

TCT ID 2: The PASCAL Transcatheter Valve Repair System for the Treatment of Tricuspid Regurgitation – Day Outcomes From the CLASP TR Early Feasibility Study

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content